Table 3 Antiplatelet and anticoagulation medication use by chronic kidney disease status (N = 934)
Medication | eGFR ≥30 n (%) | eGFR < 30 n (%) |
|---|---|---|
Anticoagulant | ||
None | 677 (80.8) | 71 (74.0) |
Warfarin | 53 (6.3) | 18 (18.7) |
NOAC | 77 (9.2) | 3 (3.1) |
Therapeutic enoxaparin | 31 (3.7) | 4 (4.2) |
Antiplatelet | ||
None | 541 (64.6) | 50 (52.1) |
Single | 250 (29.8) | 35 (36.5) |
Dual agent | 47 (5.6) | 11 (11.5) |